# Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

> **NCT00527683** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 100 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Vigabatrin
- **DRUG:** Placebo
- **BEHAVIORAL:** Group therapy

## Key facts

- **NCT ID:** NCT00527683
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2008-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527683, "Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00527683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*